Literature DB >> 28380381

FGF21 Regulates Metabolism Through Adipose-Dependent and -Independent Mechanisms.

Lucas D BonDurant1, Magdalene Ameka1, Meghan C Naber1, Kathleen R Markan1, Sharon O Idiga1, Michael R Acevedo2, Susan A Walsh2, David M Ornitz3, Matthew J Potthoff4.   

Abstract

FGF21 is an endocrine hormone that regulates energy homeostasis and insulin sensitivity. The mechanism of FGF21 action and the tissues responsible for these effects have been controversial, with both adipose tissues and the central nervous system having been identified as the target site mediating FGF21-dependent increases in insulin sensitivity, energy expenditure, and weight loss. Here we show that, while FGF21 signaling to adipose tissue is required for the acute insulin-sensitizing effects of FGF21, FGF21 signaling to adipose tissue is not required for its chronic effects to increase energy expenditure and lower body weight. Also, in contrast to previous studies, we found that adiponectin is dispensable for the metabolic effects of FGF21 in increasing insulin sensitivity and energy expenditure. Instead, FGF21 acutely enhances insulin sensitivity through actions on brown adipose tissue. Our data reveal that the acute and chronic effects of FGF21 can be dissociated through adipose-dependent and -independent mechanisms.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  FGF21; adiponectin; adipose; betaklotho; brown; glucose; homeostasis; insulin; sensitivity; white

Mesh:

Substances:

Year:  2017        PMID: 28380381      PMCID: PMC5494834          DOI: 10.1016/j.cmet.2017.03.005

Source DB:  PubMed          Journal:  Cell Metab        ISSN: 1550-4131            Impact factor:   27.287


  31 in total

1.  Tissue-specific expression of betaKlotho and fibroblast growth factor (FGF) receptor isoforms determines metabolic activity of FGF19 and FGF21.

Authors:  Hiroshi Kurosu; Mihwa Choi; Yasushi Ogawa; Addie S Dickson; Regina Goetz; Anna V Eliseenkova; Moosa Mohammadi; Kevin P Rosenblatt; Steven A Kliewer; Makoto Kuro-o
Journal:  J Biol Chem       Date:  2007-07-10       Impact factor: 5.157

2.  Transcriptional control of adipose lipid handling by IRF4.

Authors:  Jun Eguchi; Xun Wang; Songtao Yu; Erin E Kershaw; Patricia C Chiu; Joanne Dushay; Jennifer L Estall; Ulf Klein; Eleftheria Maratos-Flier; Evan D Rosen
Journal:  Cell Metab       Date:  2011-03-02       Impact factor: 27.287

3.  The effects of LY2405319, an FGF21 analog, in obese human subjects with type 2 diabetes.

Authors:  Gregory Gaich; Jenny Y Chien; Haoda Fu; Leonard C Glass; Mark A Deeg; William L Holland; Alexei Kharitonenkov; Thomas Bumol; Holger K Schilske; David E Moller
Journal:  Cell Metab       Date:  2013-09-03       Impact factor: 27.287

4.  Brown adipose tissue activity controls triglyceride clearance.

Authors:  Alexander Bartelt; Oliver T Bruns; Rudolph Reimer; Heinz Hohenberg; Harald Ittrich; Kersten Peldschus; Michael G Kaul; Ulrich I Tromsdorf; Horst Weller; Christian Waurisch; Alexander Eychmüller; Philip L S M Gordts; Franz Rinninger; Karoline Bruegelmann; Barbara Freund; Peter Nielsen; Martin Merkel; Joerg Heeren
Journal:  Nat Med       Date:  2011-01-23       Impact factor: 53.440

5.  A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance.

Authors:  J C Brüning; M D Michael; J N Winnay; T Hayashi; D Hörsch; D Accili; L J Goodyear; C R Kahn
Journal:  Mol Cell       Date:  1998-11       Impact factor: 17.970

6.  Acute glucose-lowering and insulin-sensitizing action of FGF21 in insulin-resistant mouse models--association with liver and adipose tissue effects.

Authors:  Jing Xu; Shanaka Stanislaus; Narumol Chinookoswong; Yvonne Y Lau; Todd Hager; Jennifer Patel; Hongfei Ge; Jen Weiszmann; Shu-Chen Lu; Melissa Graham; Jim Busby; Randy Hecht; Yue-Sheng Li; Yang Li; Richard Lindberg; Murielle M Véniant
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-08-25       Impact factor: 4.310

7.  Increased beta -oxidation but no insulin resistance or glucose intolerance in mice lacking adiponectin.

Authors:  Ke Ma; Agatha Cabrero; Pradip K Saha; Hideto Kojima; Lan Li; Benny Hung-Junn Chang; Antoni Paul; Lawrence Chan
Journal:  J Biol Chem       Date:  2002-07-31       Impact factor: 5.157

8.  Regulation of glucose tolerance and sympathetic activity by MC4R signaling in the lateral hypothalamus.

Authors:  Donald A Morgan; Latisha N McDaniel; Terry Yin; Michael Khan; Jingwei Jiang; Michael R Acevedo; Susan A Walsh; Laura L Boles Ponto; Andrew W Norris; Michael Lutter; Kamal Rahmouni; Huxing Cui
Journal:  Diabetes       Date:  2015-01-20       Impact factor: 9.461

9.  Fibroblast growth factor receptor 1 signaling in adult cardiomyocytes increases contractility and results in a hypertrophic cardiomyopathy.

Authors:  Sarah N Cilvik; Joy I Wang; Kory J Lavine; Keita Uchida; Angela Castro; Carolyn M Gierasch; Carla J Weinheimer; Stacey L House; Attila Kovacs; Colin G Nichols; David M Ornitz
Journal:  PLoS One       Date:  2013-12-11       Impact factor: 3.240

10.  βKlotho is required for fibroblast growth factor 21 effects on growth and metabolism.

Authors:  Xunshan Ding; Jamie Boney-Montoya; Bryn M Owen; Angie L Bookout; Katie Colbert Coate; David J Mangelsdorf; Steven A Kliewer
Journal:  Cell Metab       Date:  2012-09-05       Impact factor: 27.287

View more
  99 in total

Review 1.  Beyond adiponectin and leptin: adipose tissue-derived mediators of inter-organ communication.

Authors:  Jan-Bernd Funcke; Philipp E Scherer
Journal:  J Lipid Res       Date:  2019-06-17       Impact factor: 5.922

2.  Metabolism: Adipose and nonadipose effects of FGF21 delineated.

Authors:  David Holmes
Journal:  Nat Rev Endocrinol       Date:  2017-04-21       Impact factor: 43.330

3.  FGF21 Signals to Glutamatergic Neurons in the Ventromedial Hypothalamus to Suppress Carbohydrate Intake.

Authors:  Sharon O Jensen-Cody; Kyle H Flippo; Kristin E Claflin; Yavuz Yavuz; Sarah A Sapouckey; Grant C Walters; Yuriy M Usachev; Deniz Atasoy; Matthew P Gillum; Matthew J Potthoff
Journal:  Cell Metab       Date:  2020-07-07       Impact factor: 27.287

4.  Cardiac myocyte KLF5 regulates body weight via alteration of cardiac FGF21.

Authors:  Christine J Pol; Nina M Pollak; Michael J Jurczak; Effimia Zacharia; Iordanes Karagiannides; Ioannis D Kyriazis; Panagiotis Ntziachristos; Diego A Scerbo; Brett R Brown; Iannis Aifantis; Gerald I Shulman; Ira J Goldberg; Konstantinos Drosatos
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2019-04-26       Impact factor: 5.187

5.  Acute loss of adipose tissue-derived adiponectin triggers immediate metabolic deterioration in mice.

Authors:  Jonathan Y Xia; Kai Sun; Chelsea Hepler; Alexandra L Ghaben; Rana K Gupta; Yu A An; William L Holland; Thomas S Morley; Andrew C Adams; Ruth Gordillo; Christine M Kusminski; Philipp E Scherer
Journal:  Diabetologia       Date:  2017-12-09       Impact factor: 10.122

Review 6.  ER-associated degradation in health and disease - from substrate to organism.

Authors:  Asmita Bhattacharya; Ling Qi
Journal:  J Cell Sci       Date:  2019-12-02       Impact factor: 5.285

7.  Recharacterizing the Metabolic State of Energy Balance in Thrifty and Spendthrift Phenotypes.

Authors:  Tim Hollstein; Alessio Basolo; Takafumi Ando; Susanne B Votruba; Mary Walter; Jonathan Krakoff; Paolo Piaggi
Journal:  J Clin Endocrinol Metab       Date:  2020-05-01       Impact factor: 5.958

Review 8.  Fibroblast Growth Factor 21: A Versatile Regulator of Metabolic Homeostasis.

Authors:  Lucas D BonDurant; Matthew J Potthoff
Journal:  Annu Rev Nutr       Date:  2018-05-04       Impact factor: 11.848

Review 9.  Metabolic Factors Determining the Susceptibility to Weight Gain: Current Evidence.

Authors:  Tim Hollstein; Paolo Piaggi
Journal:  Curr Obes Rep       Date:  2020-06

Review 10.  Impact of acute exercise on immediate and following early post-exercise FGF-21 concentration in adults: systematic review and meta-analysis.

Authors:  Mousa Khalafi; Karim Azali Alamdari; Michael E Symonds; Hadi Nobari; Jorge Carlos-Vivas
Journal:  Hormones (Athens)       Date:  2020-11-05       Impact factor: 2.885

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.